IPP Bureau
Apollo’s Apollo Connect program bets big on expanding access and elevating care
By IPP Bureau - August 29, 2023
Aims to build the largest connected healthcare ecosystem in India
Global Hospitals Parel Mumbai completes 100 successful robotic surgeries
By IPP Bureau - August 29, 2023
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
Briefs: Granules India
By IPP Bureau - August 28, 2023
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Lupin receives approval from USFDA for Pirfenidone Tablets
By IPP Bureau - August 28, 2023
This product will be manufactured at Lupin's Pithampur facility in India
Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
By IPP Bureau - August 28, 2023
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
IBL Healthcare invests in KNISS Laboratories
By IPP Bureau - August 28, 2023
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Gland Pharma receives 2 observations under 483 for Pashamylaram facility
By IPP Bureau - August 28, 2023
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Zydus receives final approval from the USFDA for zinc sulfate injection pharmacy bulk package vials
By IPP Bureau - August 25, 2023
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
Lynparza plus abi/pred approved in Japan for treatment of prostate cancer
By IPP Bureau - August 25, 2023
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Roche provides update on Phase III Skyscraper-01 study in PD-L1-high metastatic non-small cell lung cancer
By IPP Bureau - August 25, 2023
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
Intuitive and Max Healthcare to launch TPO Centre for robotic-assisted surgery
By IPP Bureau - August 25, 2023
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData
By IPP Bureau - August 25, 2023
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ
By IPP Bureau - August 24, 2023
The company has entered into a three-year Deferred Prosecution Agreement
Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals
By IPP Bureau - August 24, 2023
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US
By IPP Bureau - August 24, 2023
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
